VySpine’s VyBrate VBR system earned the FDA’s 510(k) clearance, according to a Jan. 13 news release.
The device combines the osseointegration properties of the OXPEKK material and the OsteoVy lattice structure. It is the first vertebral body replacement device on the market made using OsteoVy PEKK.
VySpine’s OsteoVy lattice structure aids in bony integration and wicking, and PEKK implants are designed for an increase in bony apposition over time compared to PEEK.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.